Fgfr2 and osteopontin domains in the developing skull vault are mutually exclusive and can be altered by locally applied FGF2

QUICK SEARCH:

[advanced]

	Author:		Keyword(s):

Home Help Feedback Subscriptions Archive Search Table of Contents

This Article

	Summary
	Full Text (PDF)
	Alert me when this article is cited
	Alert me if a correction is posted

Services

	Email this article to a friend
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new issues of the journal
	Download to citation manager


Citing Articles

	Citing Articles via HighWire
	Citing Articles via Google Scholar

Google Scholar

	Articles by Iseki, S.
	Articles by Morriss-Kay, G. M.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Iseki, S.
	Articles by Morriss-Kay, G. M.


Social Bookmarking

	What's this?

Alvarez-Bolado, G., Rosenfeld, M. G. and Swanson, L. W (1995). Model of forebrain regionalisation based on spatio-temporal patterns of POU-III homeobox gene expression, birthdates, and morphological features. J. Comp. Neurol 355, 237-295.[Medline]

Bellus, G. A., Gaudenz, K., Zackai, E. H., Clarke, L. A., Szabo, J., Francomano, C. A. and Muenke, M (1996). Identical mutations in three different fibroblast growth factor receptor genes in autosomal dominant craniosynostosis syndromes. Nature Genetics 14, 174-176.[Medline]

Bresnick, S. and Schendel, S (1995). Crouzon's disease correlates with low fibroblastic growth factor receptor activity in stenosed cranial sutures. J. Craniofac. Surg 6, 245-248.[Medline]

Cinalli, G., Renier, D., Sebag, G., Sainte-Rose, C., Arnaud, E. and Pierre-Kahn, A (1995). Cronic tonsillar herniation in Crouzon's and Apert's syndromes: the role of premature synostosis of the lambdoid suture. J. Neurosurg 83, 575-582.[Medline]

Colvin, J. S., Bohne, B. A., Harding, G. W., McEwen, D. G. and Ornitz, D. M (1996). Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3. Nat. Genet 12, 390-397.[Medline]

Deng, C., Wynshaw-Boris, A., Shen, M., Daugherty, C., Ornitz, D. M. and Leder, P (1994). Murine FGFR-1 is required for early postimplantation growth and axial organization. Genes Dev 8, 3045-3058.[Abstract/Free Full Text]

Deng, C., Wynshaw-Boris, A., Zhou F., Kuo, A. and Leder P (1996). Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell 84, 911-921.[Medline]

El Ghouzzi, V. E., Le Merrer, M. L., Perrin-Schmitt, F., Lajeunie, E., Benit, P., Renier, D., Bourgeois, P., Bolcato-Bellemin, A-L., Munnich, A. and Bonaventure, J (1997). Mutations of the TWIST gene in the Saethre-Chotzen syndrome. Nature Genet 15, 42-46.[Medline]

Fedarko, N. S., Vetter, U. K., Weinstein, S. and Robey, P. G (1992). Age-related changes in hyaluronan, proteoglycan, collagen and osteonectin synthesis by human bone cells. J. Cell Physiol 151, 215-227.[Medline]

Flaumenhaft, R., Moscatelli, D., Saksela, O. and Rifkin, D. B (1989). Role of extracellular matrix in the action of basic fibroblast growth factor: matrix as a source of growth factor for long-term stimulation of plasminogen activator and DNA synthesis. J. Cell Physiol 140, 75-81.[Medline]

Flaumenhaft, R., Moscatelli, D. and Rifkin, D.B (1990). Heparin and heparan sulphate increase the radius of diffusion and action of basic fibroblast growth factor. J. Cell Biol 111, 1651-1659.[Abstract/Free Full Text]

Folkman, J., Klagsbrun, M., Sasse, J., Wadzinski, M., Ingber, D. and Vlodavsky, I (1988). A heparin-binding angiogenic protein \320 basicfibroblast growth factor \320 is stored within basement membrane. Am. J. Pathol 130, 393-400.[Abstract]

Galvin, B. D., Hart, K. C., Meyer, A. N. and Webster, M. K (1996). Constitutive receptor activation by Crouzon syndrome mutations in fibroblast growth factor receptor (FGFR)2 and FGFR2/Neu chimaeras. Proc. Natl. Acad. Sci. USA 93, 7894-9.[Abstract/Free Full Text]

Howard, T. D., Paznekas, W. A., Green, E. D., Chiang, L. C., Ma, N., Ortiz De Luna, R. I., Delgado, C. G., Gonzalez-Ramos, M., Kline, A. D. and Jabs, E. W (1997). Mutations in TWIST , a basic helix-loop-helix transcription factor, in Saethre-Chotzen syndrome. Nature Genet 15, 36-41.[Medline]

Johnson, D. E. and Williams, L. T (1993). Structural and functional diversity in the FGF receptor multigene family. Adv. Cancer. Res 60, 1-41.[Medline]

Mason, I. J (1994). The ins and outs of fibroblast growth factors. Cell 78, 547-552.[Medline]

Miki, T., Bottaro, D. P., Fleming, T. P., Smith, C. L., Burgess, W. H., Chan, A-M. L. and Aaronson, S. A (1992). Determination of ligand-binding specificity by alternative splicing: two distinct growth factor receptors encoded by a single gene. Proc. Natl. Acad. Sci. USA 89, 246-250.[Abstract/Free Full Text]

Moloney, D. M., Wall, S. A., Ashworth, G. J., Oldridge, M., Glass, I. A., Francomano, C. A., Menke, M. and Wilkie, A. O. M (1997). Prevalence of Pro250Arg mutation of fibroblast growth factor receptor 3 in coronal craniosynostosis. Lancet 349, 1059-1062.[Medline]

Moscatelli, D (1994). Autocrine downregulation of fibroblast growth factor receptors in F9 teratocarcinoma cells. J. Cell Physiol 160, 555-62.[Medline]

Muenke, M., Schell, U., Hehr, A., Robin, N. H., Losken, H. W., Schinzel, A., Pulleyn, L. J., Rutland, P., Reardon, W., Malcolm, S. and Winter, R. M (1994). A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome. Nature Genet 8, 269-274.[Medline]

Muenke, M. and Schell, U (1995). Fibroblast-growth-factor receptor mutations in human skeletal disorders. Trends Genet 11, 308-313.[Medline]

Naski, M. C., Wang, Q., Xu, J. and Ornitz, D. M (1996). Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia. Nature Genet 13, 233-237.[Medline]

Neilson, K. M. and Friesel, R. E (1995). Constitutive activation of fibroblast growth factor receptor-2 by a point mutation associated with Crouzon syndrome. J. Biol. Chem 270, 26037-26040.[Abstract/Free Full Text]

Neilson, K. M. and Friesel, R. E (1996). Ligand-independent activation of fibroblast growth factor receptors by point mutations in the extracellular, transmembrane and kinase domains. J. Biol. Chem 271, 25049-57.[Abstract/Free Full Text]

Nomura, S., Wills, A. J., Edwards, D. R., Heath, J. K. and Hogan, B (1988). Developmental expression of 2ar (osteopontin) and SPARC (osteonectin) RNA as revealed by in situ hybridization. J. Cell Biol 106, 441-450.[Abstract/Free Full Text]

Opperman, L. A., Sweeney, T. M., Redmon, J., Persing, J. A. and Ogle, R. C (1993). Tissue interactions with underlying dura mater inhibit osseous obliteration of developing cranial sutures. Dev. Dynam 198, 312-322.[Medline]

Ornitz, D. M., Xu, J., Colvin, J. S., McEwan, D. G., MacArthur, C. A., Coulier, F., Gao, G. and Goldfarb, M (1996). Receptor specificity of the fibroblast growth factor family. J. Biol. Chem 271, 15292-15297.[Abstract/Free Full Text]

Orr-Urtreger, A., Bedford, M. T., Burakova, T., Arman, E., Zimmer, Y., Yayon, A., Givol, D. and Lonai, P (1993). Developmental localization of the splicing alternatives of fibroblast growth factor receptor-2 (FGFR2). Dev. Biol 158, 475-486.[Medline]

Peters, K. G., Werner, G., Chen, G. and Williams, L. T (1992). Two FGF receptor genes are differentially expressed in epithelial and mesenchymal tissues during limb formation and organogenesis in the mouse. Development 114, 233-243.[Abstract]

Pryzlepa, K. A., Paznekas, W., Zhang, M., Golabi, M., Bias, W., Bamshad, M. J., Carey, J. C., Hall, B. D., Stevenson, R., Orlow, S., Cohen, M. M. Jr. and Jabs, E. W (1996). Fibroblast growth factor receptor 2 mutations in Beare-Stevenson cutis gyrata syndrome. Nature Genet 13, 492-494.[Medline]

Raz, V., Kelman, Z., Avivi, A., Neufield, G., Givol, D. and Yarden, Y (1991). PCR-based identification of new receptors: molecular cloning of a receptor for fibroblast growth factors. Oncogene 6, 753-760.[Medline]

Rousseau, F., Bonaventure, J., Legeai-Mallet, L., Pelet, A., Rozet, J.M., Maroteaux, P., LeMerrer, M. and Munnich, A (1994). Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature 371, 252-254.[Medline]

Shiang, R., Thompson, L. M., Zhou, Y. Z., Church, D. M., Fielder, T. J., Bocian, M., Winokur, S. T. and Wasmuth, J. J (1994). Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism. Cell 78, 335-342.[Medline]

Shimamura, K., Hartigan, D. J., Martinez, S., Puelles, L. and Rubenstein, J. L. R (1995). Longitudinal organization of the anterior neural plate and neural tube. Development 121, 3923-3933.[Abstract]

Smallwood, P. M., Munoz-Sanjuan, I., Tang, P., Macke, J. P., Hendry, S. H. C., Gilbert, D. J., Copeland, N. G., Jenkins, N. A. and Nathans, J (1996). Fibroblast growth factor (FGF) homologous factors: new members of the FGF family implicated in nervous system development. Proc. Natl. Acad. Sci. USA 93, 9850-9857.[Abstract/Free Full Text]

Su, W-C. S., Kitagawa, M., Xue, N., Xie, B., Garofalo, S., Cho, J., Deng, C., Horton, W. A. and Fu, X-Y (1997). Activation of Stat1 by mutant fibroblast growth factor receptor activity in thanatophoric dysplasia type II dwarfism. Nature 386, 288-292.[Medline]

Tavormina, P. L., Rimoin, D. L., Cohn, D. H., Zhu, Y-Z., Shiang, R. and Wasmuth, J. J (1995). Another mutation that results in the substitution of an unpaired cysteine residue in the extracellular domain of FGFR3 in thanatophoric dysplasia type 1. Hum. Mol. Genet 4, 2175-2177.[Free Full Text]

Webster, M. K. and Donoghue, D. J (1996). Constitutive activation of fibroblast growth factor receptor 3 by the transmembrane domain point mutation found in achondroplasia. EMBO J 15, 520-527.[Medline]

Webster, M. K. and Donoghue, D. J (1997). FGFR activation in skeletal disorders: too much of a good thing. Trends Genet 13, 178-182.[Medline]

Wilkie, A. O. M., Morriss-Kay, G. M., Jones, E. Y. and Heath, J. K (1995). Functions of fibroblast growth factors and their receptors. Curr. Biol 5, 500-507.[Medline]

Wilkie, A. O. M. and Wall, S. A (1996). Craniosynostosis: novel insights into pathogenesis and treatment. Curr. Opin. Neurobiol 9, 146-152.

Wood, H. B., Ward, S. J. and Morriss-Kay, G. M (1996). Effects of all- trans -retinoic acid on skeletal pattern, 5' HoxD gene expression, and RAR 2/ 4 promoter activity in embryonic mouse limbs. Dev. Genet 18, 74-84.

Yamaguchi, T. P (1994). fgfr-1 is required for embryonic growth and mesodermal patterning during mouse gastrulation. Genes. Dev 8, 3032-3044.[Abstract/Free Full Text]

Yamasaki, M., Miyake, A., Tagashira, S. and Itoh, N (1996). Structure and expression of the rat mRNA encoding a novel member of the fibroblast growth factor family. J. Biol. Chem 271, 15918-15921.[Abstract/Free Full Text]

Yayon, A., Klagsbrun, M., Esko, J. D., Leder, P. and Ornitz, D. M (1991). Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 64, 841-848.[Medline]

Yayon, A., Zimmer,Y., Guo-Hong, S., Avivi, A., Yarden, Y. and Givol, D (1992). A confined variable region confers ligand binding specificity on fibroblast growth factor receptors: Implications for the origin of the immunoglobin fold. EMBO J 11, 1885-1890.[Medline]

CiteULike

Complore

Connotea

Del.icio.us Add to Digg

Digg

Technorati

Twitter What's this?

This article has been cited by other articles:

J. Kalinina, S. A. Byron, H. P. Makarenkova, S. K. Olsen, A. V. Eliseenkova, W. J. Larochelle, M. Dhanabal, S. Blais, D. M. Ornitz, L. A. Day, et al.
Homodimerization Controls the Fibroblast Growth Factor 9 Subfamily's Receptor Binding and Heparan Sulfate-Dependent Diffusion in the Extracellular Matrix
Mol. Cell. Biol., September 1, 2009; 29(17): 4663 - 4678.
[Abstract] [Full Text] [PDF]

J. T. Rawlins, C. R. Fernandez, M. E. Cozby, and L. A. Opperman
Timing of Egf Treatment Differentially Affects Tgf-{beta}2 Induced Cranial Suture Closure
Experimental Biology and Medicine, December 1, 2008; 233(12): 1518 - 1526.
[Abstract] [Full Text] [PDF]

S. Li, N. Quarto, and M. T. Longaker
Dura mater-derived FGF-2 mediates mitogenic signaling in calvarial osteoblasts
Am J Physiol Cell Physiol, December 1, 2007; 293(6): C1834 - C1842.
[Abstract] [Full Text] [PDF]

M. Tanaka, S. Okudaira, Y. Kishi, R. Ohkawa, S. Iseki, M. Ota, S. Noji, Y. Yatomi, J. Aoki, and H. Arai
Autotaxin Stabilizes Blood Vessels and Is Required for Embryonic Vasculature by Producing Lysophosphatidic Acid
J. Biol. Chem., September 1, 2006; 281(35): 25822 - 25830.
[Abstract] [Full Text] [PDF]

R. A. Deckelbaum, A. Majithia, T. Booker, J. E. Henderson, and C. A. Loomis
The homeoprotein engrailed 1 has pleiotropic functions in calvarial intramembranous bone formation and remodeling
Development, January 1, 2006; 133(1): 63 - 74.
[Abstract] [Full Text] [PDF]

Y. Tanimoto, M. Yokozeki, K. Hiura, K. Matsumoto, H. Nakanishi, T. Matsumoto, P. J. Marie, and K. Moriyama
A Soluble Form of Fibroblast Growth Factor Receptor 2 (FGFR2) with S252W Mutation Acts as an Efficient Inhibitor for the Enhanced Osteoblastic Differentiation Caused by FGFR2 Activation in Apert Syndrome
J. Biol. Chem., October 29, 2004; 279(44): 45926 - 45934.
[Abstract] [Full Text] [PDF]

M. K. Hajihosseini, M. D. Lalioti, S. Arthaud, H. R. Burgar, J. M. Brown, S. R. F. Twigg, A. O. M. Wilkie, and J. K. Heath
Skeletal development is regulated by fibroblast growth factor receptor 1 signalling dynamics
Development, January 15, 2004; 131(2): 325 - 335.
[Abstract] [Full Text] [PDF]

C. M. Cowan, N. Quarto, S. M. Warren, A. Salim, and M. T. Longaker
Age-related Changes in the Biomolecular Mechanisms of Clvarial Osteoblast Biology Affect Fibroblast Growth Factor-2 Signaling and Osteogenesis
J. Biol. Chem., August 22, 2003; 278(34): 32005 - 32013.
[Abstract] [Full Text] [PDF]

V. P. Eswarakumar, E. Monsonego-Ornan, M. Pines, I. Antonopoulou, G. M. Morriss-Kay, and P. Lonai
The IIIc alternative of Fgfr2 is a positive regulator of bone formation
Development, March 10, 2003; 129(16): 3783 - 3793.
[Abstract] [Full Text] [PDF]

D. M. Ornitz and P. J. Marie
FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease
Genes & Dev., June 15, 2002; 16(12): 1446 - 1465.
[Full Text] [PDF]

N. Ohbayashi, M. Shibayama, Y. Kurotaki, M. Imanishi, T. Fujimori, N. Itoh, and S. Takada
FGF18 is required for normal cell proliferation and differentiation during osteogenesis and chondrogenesis
Genes & Dev., April 1, 2002; 16(7): 870 - 879.
[Abstract] [Full Text] [PDF]

M. K. Hajihosseini, S. Wilson, L. De Moerlooze, and C. Dickson
A splicing switch and gain-of-function mutation in FgfR2-IIIc hemizygotes causes Apert/Pfeiffer-syndrome-like phenotypes
PNAS, March 27, 2001; 98(7): 3855 - 3860.
[Abstract] [Full Text] [PDF]

K. Yu, A. B. Herr, G. Waksman, and D. M. Ornitz
Loss of fibroblast growth factor receptor 2 ligand-binding specificity in Apert syndrome
PNAS, December 19, 2000; 97(26): 14536 - 14541.
[Abstract] [Full Text] [PDF]

Y.-X. Zhou, X. Xu, L. Chen, C. Li, S. G. Brodie, and C.-X. Deng
A Pro250Arg substitution in mouse Fgfr1 causes increased expression of Cbfa1 and premature fusion of calvarial sutures
Hum. Mol. Genet., August 12, 2000; 9(13): 2001 - 2008.
[Abstract] [Full Text] [PDF]

A. Mansukhani, P. Bellosta, M. Sahni, and C. Basilico
Signaling by Fibroblast Growth Factors (Fgf) and Fibroblast Growth Factor Receptor 2 (Fgfr2)-Activating Mutations Blocks Mineralization and Induces Apoptosis in Osteoblasts
J. Cell Biol., June 12, 2000; 149(6): 1297 - 1308.
[Abstract] [Full Text] [PDF]

H. Makarenkova, M Ito, V Govindarajan, S. Faber, L Sun, G McMahon, P. Overbeek, and R. Lang
FGF10 is an inducer and Pax6 a competence factor for lacrimal gland development
Development, January 6, 2000; 127(12): 2563 - 2572.
[Abstract] [PDF]

D. Rice, T Aberg, Y Chan, Z Tang, P. Kettunen, L Pakarinen, R. Maxson, and I Thesleff
Integration of FGF and TWIST in calvarial bone and suture development
Development, January 5, 2000; 127(9): 1845 - 1855.
[Abstract] [PDF]

S Iseki, A. Wilkie, and G. Morriss-Kay
Fgfr1 and Fgfr2 have distinct differentiation- and proliferation-related roles in the developing mouse skull vault
Development, January 12, 1999; 126(24): 5611 - 5620.
[Abstract] [PDF]

H. Kim, D. Rice, P. Kettunen, and I Thesleff
FGF-, BMP- and Shh-mediated signalling pathways in the regulation of cranial suture morphogenesis and calvarial bone development
Development, January 4, 1998; 125(7): 1241 - 1251.
[Abstract] [PDF]

This Article

Summary

Full Text (PDF)

Alert me when this article is cited

Alert me if a correction is posted

Services

Email this article to a friend

Similar articles in this journal

Similar articles in PubMed

Alert me to new issues of the journal

Download to citation manager

Citing Articles

Citing Articles via HighWire

Citing Articles via Google Scholar

Google Scholar

Articles by Iseki, S.

Articles by Morriss-Kay, G. M.

Search for Related Content

PubMed

PubMed Citation

Articles by Iseki, S.

Articles by Morriss-Kay, G. M.

Social Bookmarking

What's this?

				J. T. Rawlins, C. R. Fernandez, M. E. Cozby, and L. A. Opperman Timing of Egf Treatment Differentially Affects Tgf-{beta}2 Induced Cranial Suture Closure Experimental Biology and Medicine, December 1, 2008; 233(12): 1518 - 1526. [Abstract] [Full Text] [PDF]

				S. Li, N. Quarto, and M. T. Longaker Dura mater-derived FGF-2 mediates mitogenic signaling in calvarial osteoblasts Am J Physiol Cell Physiol, December 1, 2007; 293(6): C1834 - C1842. [Abstract] [Full Text] [PDF]

				M. Tanaka, S. Okudaira, Y. Kishi, R. Ohkawa, S. Iseki, M. Ota, S. Noji, Y. Yatomi, J. Aoki, and H. Arai Autotaxin Stabilizes Blood Vessels and Is Required for Embryonic Vasculature by Producing Lysophosphatidic Acid J. Biol. Chem., September 1, 2006; 281(35): 25822 - 25830. [Abstract] [Full Text] [PDF]

				R. A. Deckelbaum, A. Majithia, T. Booker, J. E. Henderson, and C. A. Loomis The homeoprotein engrailed 1 has pleiotropic functions in calvarial intramembranous bone formation and remodeling Development, January 1, 2006; 133(1): 63 - 74. [Abstract] [Full Text] [PDF]

				Y. Tanimoto, M. Yokozeki, K. Hiura, K. Matsumoto, H. Nakanishi, T. Matsumoto, P. J. Marie, and K. Moriyama A Soluble Form of Fibroblast Growth Factor Receptor 2 (FGFR2) with S252W Mutation Acts as an Efficient Inhibitor for the Enhanced Osteoblastic Differentiation Caused by FGFR2 Activation in Apert Syndrome J. Biol. Chem., October 29, 2004; 279(44): 45926 - 45934. [Abstract] [Full Text] [PDF]

				M. K. Hajihosseini, M. D. Lalioti, S. Arthaud, H. R. Burgar, J. M. Brown, S. R. F. Twigg, A. O. M. Wilkie, and J. K. Heath Skeletal development is regulated by fibroblast growth factor receptor 1 signalling dynamics Development, January 15, 2004; 131(2): 325 - 335. [Abstract] [Full Text] [PDF]

				C. M. Cowan, N. Quarto, S. M. Warren, A. Salim, and M. T. Longaker Age-related Changes in the Biomolecular Mechanisms of Clvarial Osteoblast Biology Affect Fibroblast Growth Factor-2 Signaling and Osteogenesis J. Biol. Chem., August 22, 2003; 278(34): 32005 - 32013. [Abstract] [Full Text] [PDF]

				V. P. Eswarakumar, E. Monsonego-Ornan, M. Pines, I. Antonopoulou, G. M. Morriss-Kay, and P. Lonai The IIIc alternative of Fgfr2 is a positive regulator of bone formation Development, March 10, 2003; 129(16): 3783 - 3793. [Abstract] [Full Text] [PDF]

				D. M. Ornitz and P. J. Marie FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease Genes & Dev., June 15, 2002; 16(12): 1446 - 1465. [Full Text] [PDF]

				N. Ohbayashi, M. Shibayama, Y. Kurotaki, M. Imanishi, T. Fujimori, N. Itoh, and S. Takada FGF18 is required for normal cell proliferation and differentiation during osteogenesis and chondrogenesis Genes & Dev., April 1, 2002; 16(7): 870 - 879. [Abstract] [Full Text] [PDF]

				M. K. Hajihosseini, S. Wilson, L. De Moerlooze, and C. Dickson A splicing switch and gain-of-function mutation in FgfR2-IIIc hemizygotes causes Apert/Pfeiffer-syndrome-like phenotypes PNAS, March 27, 2001; 98(7): 3855 - 3860. [Abstract] [Full Text] [PDF]

				K. Yu, A. B. Herr, G. Waksman, and D. M. Ornitz Loss of fibroblast growth factor receptor 2 ligand-binding specificity in Apert syndrome PNAS, December 19, 2000; 97(26): 14536 - 14541. [Abstract] [Full Text] [PDF]

				Y.-X. Zhou, X. Xu, L. Chen, C. Li, S. G. Brodie, and C.-X. Deng A Pro250Arg substitution in mouse Fgfr1 causes increased expression of Cbfa1 and premature fusion of calvarial sutures Hum. Mol. Genet., August 12, 2000; 9(13): 2001 - 2008. [Abstract] [Full Text] [PDF]

				A. Mansukhani, P. Bellosta, M. Sahni, and C. Basilico Signaling by Fibroblast Growth Factors (Fgf) and Fibroblast Growth Factor Receptor 2 (Fgfr2)-Activating Mutations Blocks Mineralization and Induces Apoptosis in Osteoblasts J. Cell Biol., June 12, 2000; 149(6): 1297 - 1308. [Abstract] [Full Text] [PDF]

				H. Makarenkova, M Ito, V Govindarajan, S. Faber, L Sun, G McMahon, P. Overbeek, and R. Lang FGF10 is an inducer and Pax6 a competence factor for lacrimal gland development Development, January 6, 2000; 127(12): 2563 - 2572. [Abstract] [PDF]

				D. Rice, T Aberg, Y Chan, Z Tang, P. Kettunen, L Pakarinen, R. Maxson, and I Thesleff Integration of FGF and TWIST in calvarial bone and suture development Development, January 5, 2000; 127(9): 1845 - 1855. [Abstract] [PDF]

				S Iseki, A. Wilkie, and G. Morriss-Kay Fgfr1 and Fgfr2 have distinct differentiation- and proliferation-related roles in the developing mouse skull vault Development, January 12, 1999; 126(24): 5611 - 5620. [Abstract] [PDF]

				H. Kim, D. Rice, P. Kettunen, and I Thesleff FGF-, BMP- and Shh-mediated signalling pathways in the regulation of cranial suture morphogenesis and calvarial bone development Development, January 4, 1998; 125(7): 1241 - 1251. [Abstract] [PDF]